R&D News | pharmaphorum

News

Merck & Co plans to file cough drug gefapixant after phase 3...

Merck & Co is planning to file a drug for unexplained or treatment-resistant cough after supportive results from two phase 3 trials.

News

AZ halts COVID-19 vaccine after safety scare, as UK faces 's...

It’s a bleak day in the fight against COVID-19, after the UK banned social gatherings of more than six people to contain growing numbers of new cases and the lead vaccine trial from AstraZe

News

Will Gottlieb follow up on Trump's promise of a bonfire of regulations?

Trump will not interfere with vaccine approval process, FDA ...

As readouts for crucial late-stage coronavirus vaccine trials approach in the coming weeks and months, the FDA's chief Stephen Hahn is moving to assuage fears that its decision-making will

News

Verona to test COPD hopeful ensifentrine in COVID-19 patient...

Verona Pharma is starting a pilot study of its inhaled respiratory diseases drug ensifentrine in patients hospitalised with COVID-19.

News

Early data shows Russia's Sputnik V COVID-19 vaccine produce...

A trial of Russia’s Sputnik V coronavirus vaccine has shown the jab produces an immune response, although the study was too small to produce conclusive findings, particularly on safety.

News

Coronavirus vaccine: how pharma is picking up the pace

Losing ground in COVID-19 vaccine race, CanSino turns to Rus...

Politicking between China and Canada threatened to slow down development of a coronavirus vaccine from CanSino Biologics, but the company says the project is back on track following regulat

Merck & Co plans to file cough drug gefapixant after phase 3...

AZ halts COVID-19 vaccine after safety scare, as UK faces 's...

Trump will not interfere with vaccine approval process, FDA ...

Verona to test COPD hopeful ensifentrine in COVID-19 patient...

Early data shows Russia's Sputnik V COVID-19 vaccine produce...

Losing ground in COVID-19 vaccine race, CanSino turns to Rus...

Why everyone should care about longevity, with Boyang Wang

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks